Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1948 36
1949 87
1950 82
1951 137
1952 130
1953 119
1954 113
1955 154
1956 150
1957 164
1958 158
1959 140
1960 138
1961 130
1962 125
1963 153
1964 185
1965 202
1966 240
1967 272
1968 305
1969 370
1970 354
1971 454
1972 480
1973 410
1974 517
1975 550
1976 722
1977 840
1978 728
1979 678
1980 985
1981 892
1982 884
1983 813
1984 966
1985 959
1986 873
1987 857
1988 833
1989 869
1990 901
1991 994
1992 947
1993 1262
1994 958
1995 747
1996 764
1997 752
1998 785
1999 798
2000 845
2001 773
2002 806
2003 804
2004 756
2005 784
2006 766
2007 737
2008 818
2009 714
2010 1026
2011 1130
2012 959
2013 767
2014 751
2015 768
2016 660
2017 816
2018 742
2019 758
2020 683
Text availability
Article attribute
Article type
Publication date

Search Results

42,126 results
Results by year
Filters applied: . Clear all
Page 1
New strategies in ovarian cancer treatment.
Lee JM, Minasian L, Kohn EC. Lee JM, et al. Cancer. 2019 Dec 15;125 Suppl 24(Suppl 24):4623-4629. doi: 10.1002/cncr.32544. Cancer. 2019. PMID: 31967682 Free PMC article. Review.
Biomarkers in ovarian cancer: To be or not to be.
Arend R, Martinez A, Szul T, Birrer MJ. Arend R, et al. Cancer. 2019 Dec 15;125 Suppl 24:4563-4572. doi: 10.1002/cncr.32595. Cancer. 2019. PMID: 31967683 Review.
Treatment of recurrent epithelial ovarian cancer.
Pignata S, Pisano C, Di Napoli M, Cecere SC, Tambaro R, Attademo L. Pignata S, et al. Cancer. 2019 Dec 15;125 Suppl 24:4609-4615. doi: 10.1002/cncr.32500. Cancer. 2019. PMID: 31967680 Review.
Pancreatic cancer-A disease in need: Optimizing and integrating supportive care.
Moffat GT, Epstein AS, O'Reilly EM. Moffat GT, et al. Cancer. 2019 Nov 15;125(22):3927-3935. doi: 10.1002/cncr.32423. Epub 2019 Aug 5. Cancer. 2019. PMID: 31381149 Review.
Surgery in recurrent ovarian cancer.
Sehouli J, Grabowski JP. Sehouli J, et al. Cancer. 2019 Dec 15;125 Suppl 24:4598-4601. doi: 10.1002/cncr.32511. Cancer. 2019. PMID: 31967681 Review.
Successful anti-CD19 CAR T-cell therapy in HIV-infected patients with refractory high-grade B-cell lymphoma.
Abramson JS, Irwin KE, Frigault MJ, Dietrich J, McGree B, Jordan JT, Yee AJ, Chen YB, Raje NS, Barnes JA, Davis B. Abramson JS, et al. Cancer. 2019 Nov 1;125(21):3692-3698. doi: 10.1002/cncr.32411. Epub 2019 Sep 10. Cancer. 2019. PMID: 31503324 No abstract available.
Vascular endothelial growth factor and programmed death-1 pathway inhibitors in renal cell carcinoma.
Mantia CM, McDermott DF. Mantia CM, et al. Cancer. 2019 Dec 1;125(23):4148-4157. doi: 10.1002/cncr.32361. Epub 2019 Sep 18. Cancer. 2019. PMID: 31532565 Review.
Blinatumomab compared with standard of care for the treatment of adult patients with relapsed/refractory Philadelphia chromosome-positive B-precursor acute lymphoblastic leukemia.
Rambaldi A, Ribera JM, Kantarjian HM, Dombret H, Ottmann OG, Stein AS, Tuglus CA, Zhao X, Kim C, Martinelli G. Rambaldi A, et al. Cancer. 2020 Jan 15;126(2):304-310. doi: 10.1002/cncr.32558. Epub 2019 Oct 18. Cancer. 2020. PMID: 31626339 Free PMC article. Clinical Trial.
Can we predict who lives long with ovarian cancer?
Bookman MA. Bookman MA. Cancer. 2019 Dec 15;125 Suppl 24:4578-4581. doi: 10.1002/cncr.32474. Cancer. 2019. PMID: 31967684 Review.
Clinical utility of hereditary cancer panel testing: Impact of PALB2, ATM, CHEK2, NBN, BRIP1, RAD51C, and RAD51D results on patient management and adherence to provider recommendations.
Vysotskaia V, Kaseniit KE, Bucheit L, Ready K, Price K, Johansen Taber K. Vysotskaia V, et al. Cancer. 2020 Feb 1;126(3):549-558. doi: 10.1002/cncr.32572. Epub 2019 Nov 4. Cancer. 2020. PMID: 31682005 Free PMC article.
42,126 results
Jump to page
Feedback